Muscular Dystrophy Clinical Trial
Official title:
Role of Autologous Mononuclear Cell Therapy in Muscular Dystrophy
NCT number | NCT02241928 |
Other study ID # | NGBSI-14 |
Secondary ID | |
Status | Withdrawn |
Phase | Phase 1 |
First received | |
Last updated | |
Start date | January 2009 |
Est. completion date | May 2019 |
Verified date | October 2018 |
Source | Neurogen Brain and Spine Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study was to analyze the effect of autologous bone marrow mononuclear cells in muscular dystrophy.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | May 2019 |
Est. primary completion date | December 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Months to 60 Years |
Eligibility |
Inclusion Criteria: - age group of 6 months and above - muscular dystrophy diagnosed on the basis of clinical presentation Exclusion Criteria: - presence of respiratory distress - presence of acute infections such as Human Immunodeficient Virus/Hepatitis B Virus/Hepatitis C Virus - malignancies - acute medical conditions such as respiratory infection, fever, hemoglobin less than 8, bleeding tendency, bone marrow disorder, left ventricular ejection fraction < 30% - pregnancy or breastfeeding |
Country | Name | City | State |
---|---|---|---|
India | Neurogen brain and spine institute | Navi Mumbai | Maharashtra |
Lead Sponsor | Collaborator |
---|---|
Neurogen Brain and Spine Institute |
India,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Manual Muscle Testing | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01834066 -
Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy.
|
Phase 1/Phase 2 | |
Recruiting |
NCT01834040 -
Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy
|
Phase 1/Phase 2 | |
Recruiting |
NCT00082108 -
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
|
||
Recruiting |
NCT00138931 -
Genetics of Cardiovascular and Neuromuscular Disease
|
||
Completed |
NCT00622453 -
Arrhythmias in Myotonic Muscular Dystrophy
|
N/A | |
Active, not recruiting |
NCT04038138 -
Clinical Trial Readiness Network FSHD France: Prospective 24 Months MRI Study
|
N/A | |
Completed |
NCT01451281 -
Studying Skeletal Muscle, Heart, and Diaphragm Imaging in Boys With Duchenne Muscular Dystrophy
|
||
Not yet recruiting |
NCT05470478 -
iBCI Optimization for Veterans With Paralysis
|
N/A | |
Completed |
NCT04154098 -
Evaluation of a Textile Scapula Orthosis
|
N/A | |
Terminated |
NCT02653833 -
The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy
|
Early Phase 1 | |
Not yet recruiting |
NCT06363526 -
Effectiveness of 5-week Digital Respiratory Practice in a Group of Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.
|
N/A | |
Completed |
NCT01990976 -
Study of Morphology and Functional Magnetic Resonance Imaging (MRI) Muscle Patients With Muscular Dystrophy Type FSHD Benefiting a Physical Training Introduced.
|
N/A | |
Completed |
NCT01393444 -
ECoG Direct Brain Interface for Individuals With Upper Limb Paralysis
|
N/A | |
Recruiting |
NCT00912041 -
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
|
N/A | |
Completed |
NCT00866112 -
A Randomized Exercise Trial for Wheelchair Users
|
N/A | |
Completed |
NCT01882400 -
Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy
|
Phase 4 | |
Recruiting |
NCT05726591 -
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
|
N/A | |
Completed |
NCT02815878 -
Enhance Wellness for Individuals With Long-Term Physical Disabilities
|
N/A | |
Completed |
NCT04035967 -
Investigation of Parents' Anxiety Level and Health Related Quality of Life in Different Types of Physical Disabilities
|
||
Not yet recruiting |
NCT06290713 -
Vasodilator and Exercise Study for DMD (VASO-REx)
|
Phase 2 |